ADAP

Adaptimmune Therapeutics

68 hedge funds and large institutions have $299M invested in Adaptimmune Therapeutics in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 19 closing their positions.

Holders
68
Holders Change
-12
Holders Change %
-15%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
7
Increased
22
Reduced
16
Closed
19
Calls
$6K
Puts
$41K
Net Calls
-$35K
Net Calls Change
-$2.15M
Name Market Value Shares Shares
Change
Shares
Change %
KBC Group
51
KBC Group
Belgium
$8K 1,900 +950 +100%
Citigroup
52
Citigroup
New York
$5K 1,135 +1,135 New
Wells Fargo
53
Wells Fargo
California
$4K 800 -1,200 -60%
PCM
54
Prelude Capital Management
New York
$4K 819 -98 -11%
Barclays
55
Barclays
United Kingdom
$4K 871 +600 +221%
QT
56
Quantamental Technologies
New York
$3K 700 +100 +17%
RE
57
RBC Europe
United Kingdom
$2.58K 600
LTFS
58
Ladenburg Thalmann Financial Services
Florida
$2K 500 -435 -47%
NFG
59
Next Financial Group
Texas
$2K 475
AG
60
Advisor Group
Arizona
$2K 400
NFH
61
NEXT Financial Holdings
Texas
$2K 475 +475 New
Bank of America
62
Bank of America
North Carolina
$1K 267 -901 -77%
Daiwa Securities Group
63
Daiwa Securities Group
Japan
$1K 323
PA
64
Parallel Advisors
California
$1K 314
ED
65
Exane Derivatives
France
$520 121
GT
66
Glenmede Trust
Pennsylvania
$1 375 +375 New
FCMI
67
Foresite Capital Management II
California
-700,000 Closed
Balyasny Asset Management
68
Balyasny Asset Management
Illinois
-567,401 Closed
A
69
Abingworth
United Kingdom
-250,000 Closed
BG
70
Bellevue Group
Switzerland
-131,135 Closed
Marshall Wace
71
Marshall Wace
United Kingdom
-130,050 Closed
Ameriprise
72
Ameriprise
Minnesota
-119,280 Closed
Squarepoint
73
Squarepoint
New York
-108,100 Closed
OIM
74
Oracle Investment Management
Connecticut
-52,921 Closed
CM
75
Caption Management
Oklahoma
-50,960 Closed